Biotech News

Paratek Pharmaceuticals to Present New Data on NUZYRA® (omadacycline) at ESCMID Global 2025

Paratek Pharmaceuticals (PRTK)Paratek PharmaceuticalsCompany update

Highlights will include data from non-clinical and real-world patient use

BOSTON, April 10, 2025 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc., a privately held pharmaceutical company developing specialty therapies for community care and public health challenges, today announced that data from several new...

Related news

Paratek Pharmaceuticals

Paratek Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

Recent company news

Stock data

Close
Market cap
Exchange
NASDAQ
Sector
Biopharma
Location
United States